WuXi XDC Cayman Inc
2268
Classificação em ações
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Preço da ação
$8.78
Valor de mercado
$11.12B
Variação (1 dia)
-9.52%
Variação (1 ano)
0.57%
País
CN
Negociar WuXi XDC Cayman Inc (2268)
Categoria
Healthcare
Rácio P/S de WuXi XDC Cayman Inc (2268)
Rácio P/S em October 2026 TTM: 10.77
De acordo com os relatórios financeiros mais recentes e o preço das ações da WuXi XDC Cayman Inc, o rácio P/S atual (TTM) é 10.77. No final de 2024, o rácio P/S era 8.51.
Histórico do rácio P/S da WuXi XDC Cayman Inc de 2020 a 2026
Rácio P/S no final de cada ano
| Ano | Rácio P/S | Alterar |
|---|---|---|
| 2026 (TTM) | 10.77 | -11.24% |
| 2025 | 12.13 | 42.53% |
| 2024 | 8.51 | -42.82% |
| 2023 | 14.89 | -49.39% |
| 2022 | 29.42 | -65.94% |
| 2021 | 86.37 | -70.02% |
| 2020 | 288.11 | 0.00% |
Rácio P/S de empresas semelhantes ou concorrentes
| Empresa | Rácio P/S | Diferença do rácio P/S | País |
|---|---|---|---|
| 5.37 | -50.10% |
US
|
|
| 6.29 | -41.56% |
US
|
|
| 21.02 | 95.24% |
US
|
|
| 6.53 | -39.37% |
CN
|
|
| 6.80 | -36.85% |
US
|
